Filter News
Area of Research
- (-) Nuclear Science and Technology (6)
- Biology and Environment (31)
- Clean Energy (63)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (2)
- Fusion and Fission (1)
- Isotopes (9)
- Materials (27)
- Materials for Computing (8)
- Mathematics (1)
- National Security (5)
- Neutron Science (12)
- Supercomputing (21)
- Transportation Systems (2)
News Topics
- (-) Biomedical (2)
- (-) Isotopes (3)
- (-) Molten Salt (3)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (6)
- Bioenergy (1)
- Computer Science (1)
- Decarbonization (1)
- Fusion (2)
- Materials Science (1)
- Neutron Science (3)
- Nuclear Energy (17)
- Physics (1)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
In the 1960s, Oak Ridge National Laboratory's four-year Molten Salt Reactor Experiment tested the viability of liquid fuel reactors for commercial power generation. Results from that historic experiment recently became the basis for the first-ever molten salt reactor benchmark.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
Experts focused on the future of nuclear technology will gather at Oak Ridge National Laboratory for the fourth annual Molten Salt Reactor Workshop on October 3–4.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.